盐酸克里唑替尼
Crizotinib hydrochloride | PF-02341066 hydrochloride
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
10 mg 25 mg 50 mg
Product Availability
3-5days
Price
$150.00
Member price
Product Availability
3-5days
Price
$245.00
Member price
Product Availability
3-5days
Price
$392.00
Member price
Quantity
- +
Product Overview
Product Name Crizotinib hydrochloride | PF-02341066 hydrochloride
CAS1415560-69-8
FormulaC21H23Cl3FN5O
MW486.80
AppearanceYellow to brown powder
Storage condition4°C, sealed storage, away from moisture
Security information
Product details

Crizotinib HCl (formerly known as PF-02341066 hydrochloride; trade name: Xalkori) is a potent, orally bioavailable small molecule inhibitor of c-Met and ALK, with IC50 values of 11 nM and 24 nM in assays involving cells, respectively. In the US, crizotinib is licensed for the treatment of non-small cell lung cancer (NSCLC). It is also being investigated in clinical trials for safety and effectiveness in the treatment of neuroblastoma, anaplastic large cell lymphoma, and other advanced solid tumors in both adults and children. Crizotinib inhibits the activation of the MET signaling pathway and the membrane receptor MET, which in susceptible tumor cell populations may prevent tumor cell growth, migration, invasion, and angiogenesis.

Related
Crizotinib (PF-02341066)
History
Crizotinib hydrochloride | PF-02341066 hydrochloride